The Committee for Clinical Research and Medicines Strategy was established in September 2018 with the purpose of defining an ACC strategy to foster Italian clinical and translational research.
The Committee, in accord with the relevant authorities and with the pharmaceutical companies, aims to broaden clinical research strategy and planning at national and international level, with ACC members taking a leading role. Its sights are also set on developing shared strategies, with AIFA and the major pharmaceutical companies, for the implementation of multicentre investigational clinical trials and Real World Clinical Trials. The Committee has set up two working groups, the Infrastructure Group and the AIFA Group, that will be focusing on their specific areas of expertise to help the Committee achieve its objectives.
- Coordinator: Paolo Pronzato - IST GENOA
- Coordinator: Sandro Pignata - PASCALE NAPLES
Bianchini Giampaolo – HSR MILAN | Biffoni Mauro – ISS ROME | Curigliano Giuseppe – IEO MILAN | De Salvo Gian Luca – IOV PADUA | Del Mastro Lucia – IST GENOA | Delmonte Angelo – IRST MELDOLA | Dufour Carlo – GASLINI GENOA | Eoli Marica – BESTA MILAN | Fratino Lucia – CRO AVIANO | Garaventa Alberto – GASLINI GENOA | Giannarelli Diana – IRE ROME | Iannelli Elisabetta – AIMAC | Locatelli Franco – OPBG ROME | Marchesi Emanuela – ISG BOLOGNA | Marchioni Enrico – MONDINO PAVIA Montemurro Filippo – IRCCS CANDIOLO | Nanni Oriana – IRST MELDOLA | Palmerini Emanuela – IOR BOLOGNA | Quintarelli Concetta – OPBG ROME | Silvestris Nicola – INT BARI | Toffoli Giuseppe – CRO AVIANO | Tortora Giampaolo – GEMELLI ROME | Zucali Paolo – ICH ROZZANO